|
 Amgen has announced the appointment of Naveen Gullapalli as its managing director. He will lead the Amgen India Technology and Innovation site in Hyderabad leveraging his extensive experience leading global operations and adjoining functions across the pharmaceutical, finance and technology industries.
Gullapalli joins Amgen from Novartis where he led the development of their global centre in Hyderabad and their network of six centres across the world where he was instrumental in driving strategic growth and innovation for the enterprise. His experience in developing specialized skills and enabling business transformation aligns closely with Amgen’s vision for its Hyderabad site as a global technology and innovation hub.
"We are thrilled to welcome Naveen. Amgen India is key to furthering our global vision of unlocking the convergence of biotech and tech to accelerate innovation and help meet the needs of a globally aging population. Naveen’s wealth of experience and strategic leadership will drive the success of this new site,” said Som Chattopadhyay, national executive for India, Amgen.
“India’s talent pool offers a compelling opportunity for Amgen to deliver world-class functional excellence, operational excellence, innovation and technology-led transformation,” said Gullapalli. “
Announced in August 2024, the technology and innovation site in Hyderabad is a critical component of Amgen's global strategy to accelerate its digital transformation and innovation efforts, aiming to further support Amgen’s mission of serving more patients. With an initial focus on building and scaling advanced technology solutions and digital capabilities, Amgen India will enhance efficiencies across the enterprise, supporting key areas such as AI, data science, and life sciences.
|